XYLOCARD Solution for injection Ref.[27837] Active ingredients: Lidocaine

Source: Health Products and Food Branch (CA)  Revision Year: 2021 

Product name

XYLOCARD Lidocaine hydrochloride

Solution, 20 mg/mL, Intravenous.

Summary product information

Dosage forms, composition and packaging

Table 2. Dosage Forms, Strengths, Composition and Packaging:

Route of AdministrationDosage Form/Strength/CompositionNon-medicinal Ingredients
Intravenous20 mg/mLSodium chloride, sodium hydroxide and/or hydrochloric acid, water for injection

XYLOCARD 100 mg is available in a 5 mL glass ampoule (contains 20 mg/mL, a 2% solution). Each carton contains 10 ampoules with a leaflet.

See DOSAGE AND ADMINISTRATION section for instructions regarding preparation of solutions for continuous intravenous infusion.

Marketing Informations Authorization Dates
Authorization holder:

Aspen Pharmacare Canada Inc., 8 – 1155 North Service Road West, Oakville, ON, L6M 3E3

Submission control number:

246218

Date of approval:

December 31, 1974

Date of revision:

May 21, 2021

Drugs

Drug Countries
XYLOCARD Canada, France

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.